JP2005538184A5 - - Google Patents

Download PDF

Info

Publication number
JP2005538184A5
JP2005538184A5 JP2004555293A JP2004555293A JP2005538184A5 JP 2005538184 A5 JP2005538184 A5 JP 2005538184A5 JP 2004555293 A JP2004555293 A JP 2004555293A JP 2004555293 A JP2004555293 A JP 2004555293A JP 2005538184 A5 JP2005538184 A5 JP 2005538184A5
Authority
JP
Japan
Prior art keywords
alkyl
haloalkyl
independently
substituents
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004555293A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005538184A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/028363 external-priority patent/WO2004047725A2/en
Publication of JP2005538184A publication Critical patent/JP2005538184A/ja
Publication of JP2005538184A5 publication Critical patent/JP2005538184A5/ja
Withdrawn legal-status Critical Current

Links

JP2004555293A 2002-09-11 2003-09-10 Hivインテグラーゼ阻害剤として有用な8−ヒドロキシ−1−オキソ−テトラヒドロピロロピラジン化合物 Withdrawn JP2005538184A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40974502P 2002-09-11 2002-09-11
PCT/US2003/028363 WO2004047725A2 (en) 2002-09-11 2003-09-10 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors

Publications (2)

Publication Number Publication Date
JP2005538184A JP2005538184A (ja) 2005-12-15
JP2005538184A5 true JP2005538184A5 (https=) 2006-10-19

Family

ID=32393259

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004555293A Withdrawn JP2005538184A (ja) 2002-09-11 2003-09-10 Hivインテグラーゼ阻害剤として有用な8−ヒドロキシ−1−オキソ−テトラヒドロピロロピラジン化合物

Country Status (7)

Country Link
US (1) US7399763B2 (https=)
EP (1) EP1539714B1 (https=)
JP (1) JP2005538184A (https=)
AT (1) ATE404563T1 (https=)
CA (1) CA2498566A1 (https=)
DE (1) DE60322919D1 (https=)
WO (1) WO2004047725A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2498111A1 (en) * 2002-09-11 2004-03-25 Merck & Co., Inc. Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
CA2542047A1 (en) * 2003-10-20 2005-05-12 Merck & Co., Inc. Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors
ES2529038T3 (es) * 2004-05-07 2015-02-16 Merck Sharp & Dohme Corp. Inhibidores de la integrasa de VIH
US7476666B2 (en) 2004-06-09 2009-01-13 Merck & Co., Inc. HIV integrase inhibitors
US20080280849A1 (en) * 2005-06-01 2008-11-13 Herve Leh Synergic Combinations Comprising a Quinoline Compound and Other Hiv Infection Therapeutic Agents
JP2009513640A (ja) * 2005-10-27 2009-04-02 メルク エンド カムパニー インコーポレーテッド Hivインテグラーゼインヒビター
WO2010031816A1 (en) 2008-09-19 2010-03-25 Nerviano Medical Sciences S.R.L. 3,4 DIHYDRO-2H-PYRROLO[1,2-a]PYRAZIN-1-ONE DERIVATIVES
PE20130010A1 (es) 2010-02-26 2013-02-05 Japan Tobacco Inc Derivado de 1,3,4,8-tetrahidro-2h-pirido[1,2-a]pirazina como inhibidor de la integrasa del vih
EP2841417A1 (en) 2012-04-26 2015-03-04 Francis Xavier Tavares Synthesis of lactams
JP7106462B2 (ja) * 2016-07-01 2022-07-26 ジー1 セラピューティクス, インコーポレイテッド N-(ヘテロアリール)-ピロロ[3,2-d]ピリミジン-2-アミンの合成
RS67557B1 (sr) 2018-08-24 2026-01-30 Pharmacosmos Holding As Unapređena sinteza 1,4-diazaspiro[5.5]undekan-3-ona

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101860A0 (en) * 1991-05-31 1992-12-30 Ici Plc Heterocyclic derivatives
US5821241A (en) * 1994-02-22 1998-10-13 Merck & Co., Inc. Fibrinogen receptor antagonists
WO2000000478A1 (en) * 1998-06-26 2000-01-06 Bristol-Myers Squibb Pharma Company Substituted quinoxalin-2(1h)-ones useful as hiv reverse transcriptase inhibitors
CA2425440C (en) 2000-10-12 2010-04-13 Merck & Co., Inc. Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
JP2004517860A (ja) 2000-10-12 2004-06-17 メルク エンド カムパニー インコーポレーテッド Hivインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類
JP2004513134A (ja) * 2000-10-12 2004-04-30 メルク エンド カムパニー インコーポレーテッド Hivインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルケトン類
US6919351B2 (en) * 2000-10-12 2005-07-19 Merck & Co., Inc. Aza-and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors
NZ533057A (en) 2001-10-26 2005-11-25 Angeletti P Ist Richerche Bio N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
EP1441734B1 (en) 2001-10-26 2007-02-28 Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
CA2498111A1 (en) * 2002-09-11 2004-03-25 Merck & Co., Inc. Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors

Similar Documents

Publication Publication Date Title
RU2483061C2 (ru) Тетрагидропиранохроменовые ингибиторы гамма-секретазы
JP2019034943A5 (https=)
JP2016518437A5 (https=)
JP2019094345A5 (https=)
JP2004516314A5 (https=)
CA2472372A1 (en) Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
JP2008514732A5 (https=)
JP2013532652A5 (https=)
JP2005538184A5 (https=)
JP2006524660A5 (https=)
JP2016530259A5 (https=)
JP2011503118A5 (https=)
JP2015531773A5 (https=)
JP2015501833A5 (https=)
KR100214453B1 (ko) 경피적 관상동맥 형성술 후의 재협착 억제제
JP2006506352A5 (https=)
JP2007528396A5 (https=)
JP2004521924A5 (https=)
JP2005526857A5 (https=)
RU2007116119A (ru) Производные циклоспорина, замещенные 3-эфиром и 3-тиоэфиром, для лечения и профилактики инфекционного гепатита с
JP2015504067A5 (https=)
JP2013209405A5 (https=)
IL205501A (en) Preparation of preparations for the treatment of arthritis
JP2006515339A5 (https=)
JP2003508524A5 (https=)